Blog

Nov 13, 2019

Scientific communication (2): does your narrative reach opinion makers?

Nov 13, 2019

Scientific communication (1): do you monitor what they say about you?

Nov 7, 2019

Does your scientific narrative reach the target audience? (2)

Nov 7, 2019

Does your scientific narrative reach the target audience? (1)

Oct 30, 2019

Different systems have different HTA needs

Vienna School of Clinical Research: tailoring HTA curriculums to participants' needs

Oct 24, 2019

German healthcare system October 2019*: increasing number of non available prescription drugs: drive

...the fact that the downwards pricing spiral leads to supply situations in which the negotiation balance tips to monopoly pharma...

Oct 17, 2019

Biosimilars: automatic substitution rules create new doctor - patient interaction challenges.

Treatment decisions should always be the result of an informed doctor - patient interaction in which the doctor keeps final prescription...

Oct 10, 2019

Biosimilars: Are reference analogs and biosimilars interchangeable?

In the field of i.e. Diabetes therapy, the Insulin biosimilar interchangeability and switching discussion is by lack of data from...

Oct 2, 2019

Pharmaceutical innovation: what’s the deal and what are outcome assumptions…

...that need to be factored into early clinical development decision making by backwards engineering the required health outcome data...

Sep 19, 2019

VSCR-SFU Health outcome research course- evidence-based decision making for pricing and reimbursemen

New diploma course series (university course) for managers of the pharmaceutical and medical technology industry (market access,...

Sep 15, 2019

Technology is there to help enable more meaningful and empathic patient-doctor relationships...

...so that algorithms free up time to discuss diagnosis and treatment options and shift the focus on to the human interaction. Suggested...

Sep 4, 2019

AI and big data are big in big pharma...

...probably not yet a spaceship to new pharma horizons - but it's clearly taking off! #BigData #BigPharma #Pharmamarket

Aug 30, 2019

The family tree of pharmaceutical pricing is in full bloom...

...and winning strategies translate relevant medical data into meaningful value propositions for payers' budgetary planning security....

Aug 19, 2019

Pharmaceuticals change from drugs to therapeutics to solutions...

...and healthcare systems expect from the industry to deliver more... #Personalizedmedicine #Therapies #Treatmentconcepts

Aug 12, 2019

Pharmaceutical industry: customer demands change...

...and so do the functions serving networks of care. Patients demand individual healthcare solutions and payers expect to pay for...

Aug 5, 2019

Pharmaceutical industry: customers and their demands change...

...and so do organisations. Driver for organisational development are new stakeholders, new technologies and above all, a new MINDSET!...

Jul 29, 2019

Pharmaceutical industry: getting closer to the customer...

...is about getting accepted as a member of networks of patient care. #Pharmamarket #Networkofcare #Patientcentricity #Customer

Jul 17, 2019

"Patient centricity is the focus for all our efforts" - Is it really?...

...and if it is - do you track the way that social media reflects "your story"? And if you do track - how do you integrate the insights...

Jul 10, 2019

MSD's corporate responsibility focusses on access to health: pricing, commercialisation, R&D

...while bioethics and ecosystem impact make it to the bottom of a grid that maps the importance of the topic to stakeholders against the...

Jul 10, 2019

European pharma markets: is HTA the new marketing?

Marketing is always the art of differentiating products in such a way that the benefits are apparent to customers. HTA assessments...

BLOG

Impressum

Privacy Policy